Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment | FDA

Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment | FDA

President Trump Announces Remdesivir Authorized for Emergency COVID-19 Treatment, Discusses Ending HIV and Hepatitis C On May 1, 2020, the President announced that the investigational antiviral drug remdesivir has been authorized by the U.S. Food and Drug Administration for emergency use to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease, and also discussed HIV and hepatitis C. LEARN MORE

May 2020 Health Observances at a Glance During May, several national health observances recognize – and call us to respond to – the breadth of the impact of HIV and viral hepatitis in our nation. In 2020, these May observances occur in the context of COVID-19. We acknowledge the public health and HIV communities for their continuing efforts to draw attention to HIV and other health issues. We also appreciate their work to respond to COVID-19 concerns for those living with/at risk for HIV and their efforts to encourage COVID-19 prevention. LEARN MORE